• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Kevin Lord, PhD, MHS

Latest:

Reports of the Demise of Chemotherapy Have Been Greatly Exaggerated

The expanding arsenal of targeted and immuno-oncology drugs has unalterably changed the landscape of systemic cancer treatment, but chemotherapy will remain critical for years if not decades to come.


Laurence F. McMahon Jr, MD, MPH

Latest:

Mixed Messages to Consumers From Medicare: Hospital Compare Grades Versus Value-Based Payment Penalty

Many hospitals penalized for readmissions were given readmission grades of “no different” or “better” than the national rate on the Hospital Compare website.



Deborah E. Welsh, MS

Latest:

"No-Shows": Who Fails to Follow Up With Initial Behavioral Health Treatment?

Patients who obtained authorization but did not get initial mental health treatment needed treatment as much as or more than patients who presented for care.







Elizabeth J. Murphy, MD, DPhil

Latest:

e-Consult Implementation Success: Lessons From 5 County-Based Delivery Systems

This case study of 5 county-based delivery systems finds that existing specialty care relationships and information technology integration are important differentiating factors for e-consult implementation success.


Joel Rosenquist, MPA

Latest:

Journey Forward: The New Face of Cancer Survivorship Care

WellPoint, UCLA's Jonsson Comprehensive Cancer Center, the National Coalition for Cancer Survivorship (NCCS) and Genentech collaborated to develop Journey Forward, a first-of-its-kind program for coordinating post-treatment care.


Lee H. Schwamm, MD

Latest:

Addressing Virtual Care Disparities for Patients With Limited English Proficiency

With increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.


Diane Croll, DNP

Latest:

Impact of After-Hours Telemedicine on Hospitalizations in a Skilled Nursing Facility

A case study highlighting clinical and financial outcomes of an after-hours on-demand telemedicine intervention in a skilled nursing facility.


Flor M. Munoz, MD

Latest:

Improving Influenza Immunization in Pregnant Women and Healthcare Workers

Influenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.



Kahyun Yoon-Flannery, MPH

Latest:

Community-Based Health Information Technology Alliances: Potential Predictors of Early Sustainability

Communities led by health information organizations were more likely than those led by healthcare organizations to receive ongoing funding for implementing health information technology.







JoAnn Stubbings, RPh, MHCA

Latest:

Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2009

Various changes to the Part D benefit were made in 2009, including availability of the data for research and increased cost of the standard benefit.


Cynthia L. Bero, MPH

Latest:

Achieving Meaningful Use: A Health System Perspective

The experience of Partners HealthCare offers some unique insights into the process of electronic medical record adoption across a large, diverse health system.



Douglas Ziedonis, MD

Latest:

Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy

The increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.


Kavita Patel, MD, MSHS

Latest:

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.


Collin G. Wolf, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.


Stephen A. Hart, MD

Latest:

Health Insurance and Racial Disparities in Pulmonary Hypertension Outcomes

In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.


© 2025 MJH Life Sciences
AJMC®
All rights reserved.